Researchers have discovered that Botox jabs can significantly improve quality of life of the people having weak bladders.

The study researchers said that an injection of the virulent toxin to control problems related to bladder reported significant impact on their social life.

In addition, the jab, which works for up to 24 weeks, also improved patients’ general health.

To come to the conclusion, UK urologists from Guy’s Hospital and King’s College London conducted a randomized, double-blind placebo test on 34 patients aged 50.

Seven men and nine women had the Botox injections while eight men and ten women were given a placebo.

After being monitored over 24 weeks, the researchers noted marked improvements in symptoms among those who had Botox.

Consultant urological surgeon Prokar Dasgupta from Guy’s Hospital and King’s College London School of Medicine explained, “The Botox or placebo injections were administered using a flexible injection needle inside a cystoscope, a long tube that enables urologists to see inside the bladder.”

“This minimally invasive technique involved 20 injections - five in the midline posterior bladder wall, five in the left lateral wall, five in the right lateral wall and five across the dome of the bladder. In all, 200ml of Botox or placebo was administered,” Dr. Dasgupta added.

The study participants in both groups were evaluated at the beginning of the study and at four, 12 and 24 weeks after they had the Botox jab.

Patients who had Botox jabs showed noteworthy improvements when it came to a number of quality of life factors.

These were assessed by using King’s Health Questionnaire, a zero to 100 scale, which was developed in the late 1990s to evaluate women with urinary incontinence.

The researchers said that the physical impact of incontinence had been reduced from 100 to 65, leaving them more convinced.

Their social restraints dropped from 72 to 39, the negative effect of the condition on their sentiments dropped from 100 to 65 and the effect on relationships declined from 67 to 50.

The impact of the condition on sleep and energy levels fell from 83 to 58.

The results of the study appeared in the UK-based urology journal BJU.